MedTrace Logo

Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms

NCT05028153 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2025-04-13

No results posted yet for this study

Summary

The purpose of this double-blind, randomized, controlled clinical trial is to investigate the effect of a three-day azithromycin treatment versus placebo treatment in children aged 1-5 years who are hospitalized due to asthma-like symptoms.

Conditions

  • Childhood Asthma With Acute Exacerbation

Interventions

DRUG

Azithromycin Oral Liquid Product

10 mg/kg for 3 consecutive days

OTHER

Placebo mixture

Placebo mixture containing no active substance

Sponsors & Collaborators

  • Copenhagen Studies on Asthma in Childhood

    lead OTHER

Principal Investigators

  • Jakob Stokholm, MD, PhD · University Hospital of Copenhagen, DK-2820 Gentofte, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
71 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-14
Primary Completion
2026-11-13
Completion
2032-11-13

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05028153 on ClinicalTrials.gov